Tectonic Therapeutic (TECX) Other Non-Current Assets (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Other Non-Current Assets came in at $663000.0 in Q1 2026, up 12.95% year-on-year from $587000.0 in Q1 2025, and up 3.59% on a QoQ basis from $640000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Other Non-Current Assets data on file, last reported at $663000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 12.95% year-over-year to $663000.0 in Q1 2026; TTM through Mar 2026 was $663000.0, a 12.95% increase from a year earlier, with the FY2025 full-year figure at $640000.0, up 310.26% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $663000.0, up from $640000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for TECX reached as high as $663000.0 in Q1 2026 and fell as low as $40000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $485352.9 across 5 years, with a median of $587000.0 in 2023.
- Across the five-year window, Other Non-Current Assets slumped 91.87% in 2022 and soared 1367.5% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $40000.0 in 2022, then surged by 1367.5% to $587000.0 in 2023, then tumbled by 73.42% to $156000.0 in 2024, then soared by 310.26% to $640000.0 in 2025, then advanced by 3.59% to $663000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $663000.0 in Q1 2026, $640000.0 in Q4 2025, and $597000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | 663,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 663,000.00 |
| Dec 31, 2025 | 640,000.00 |
| Sep 30, 2025 | 597,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 587,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 587,000.00 |
| Jun 30, 2024 | 587,000.00 |
| Mar 31, 2024 | 587,000.00 |
| Dec 31, 2023 | 587,000.00 |
| Sep 30, 2023 | 587,000.00 |
| Jun 30, 2023 | 587,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 492,000.00 |
| Mar 31, 2022 | 492,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 492,000.00 |
| Jun 30, 2021 | 492,000.00 |